United States · FDA National Drug Code directory
Lansoprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 27241-020_1e0a31f6-b245-43a0-81f4-8654c4b381d2
- Product NDC
- 27241-020
- Form
- CAPSULE, DELAYED RELEASE
- Composition / generic term
- Lansoprazole
- Labeler
- Ajanta Pharma USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161018
- Source listing expiry
- 20261231
Source-listed ingredients
- LANSOPRAZOLE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-020-03) · 27241-020-03
- 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-020-09) · 27241-020-09
- 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-020-10) · 27241-020-10
- 500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-020-50) · 27241-020-50
- 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (27241-020-90) · 27241-020-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →